Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Cancer. 2015 Feb 11;121(11):1800–1808. doi: 10.1002/cncr.29290

Figure 3.

Figure 3

Overall survival curves (A: n=1,133) and lymphoma-related survival curves (B: n=984) for patients greater than 80 years old, by treatment regimen. CHOP=cyclophosphamide, doxorubicin, vincristine, prednisone; R-CHOP=rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; R-CVP=rituximab, cyclophosphamide, vincristine, prednisone; OS=overall survival; LRS=lymphoma-related survival. Patients treated with CVP (cyclophosphamide, vincristine, prednisone) were removed in order to prevent patient identification.